Title of article :
Sildenafil Stops Progressive Chamber, Cellular, and Molecular Remodeling and Improves Calcium Handling and Function in Hearts With Pre-Existing Advanced Hypertrophy Caused by Pressure Overload
Author/Authors :
Nagayama، نويسنده , , Takahiro and Hsu، نويسنده , , Steven and Zhang، نويسنده , , Manling and Koitabashi، نويسنده , , Norimichi and Bedja، نويسنده , , Djahida and Gabrielson، نويسنده , , Kathleen L. and Takimoto، نويسنده , , Eiki and Kass، نويسنده , , David A.، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2009
Pages :
9
From page :
207
To page :
215
Abstract :
Objective tudy sought to test the efficacy of phosphodiesterase type 5A (PDE5A) inhibition for treating advanced hypertrophy/remodeling caused by pressure overload, and to elucidate cellular and molecular mechanisms for this response. ound afil (SIL) inhibits cyclic guanosine monophosphate–specific PDE5A and can blunt the evolution of cardiac hypertrophy and dysfunction in mice subjected to pressure overload. Whether and how it ameliorates more established advanced disease and dysfunction is unknown. s ere subjected to transverse aortic constriction (TAC) for 3 weeks to establish hypertrophy/dilation, and subsequently treated with SIL (100 mg/kg/day) or placebo for 6 weeks of additional TAC. s L arrested further progressive chamber dilation, dysfunction, fibrosis, and molecular remodeling, increasing myocardial protein kinase G activity. Isolated myocytes from TAC-SIL hearts showed greater sarcomere shortening and relaxation, and enhanced Ca2+ transients and decay compared with nontreated TAC hearts. The SIL treatment restored gene and protein expression of sarcoplasmic reticulum Ca2+ uptake adenosine triphosphatase (SERCA2a), phospholamban (PLB), and increased PLB phosphorylation (S16), consistent with improved calcium handling. The phosphatase calcineurin (Cn) and/or protein kinase C-α (PKCα) can both lower phosphorylated phospholamban and depress myocyte calcium cycling. The Cn expression and PKCα activation (outer membrane translocation) were enhanced by chronic TAC and reduced by SIL treatment. Expression of PKCδ and PKCε also increased with TAC but were unaltered by SIL treatment. sions eatment applied to well-established hypertrophic cardiac disease can prevent further cardiac and myocyte dysfunction and progressive remodeling. This is associated with improved calcium cycling, and reduction of Cn and PKCα activation may be important to this improvement.
Keywords :
PDE5 , pressure overload , Hypertrophy , Myocyte , Cardiac Function
Journal title :
JACC (Journal of the American College of Cardiology)
Serial Year :
2009
Journal title :
JACC (Journal of the American College of Cardiology)
Record number :
1743832
Link To Document :
بازگشت